The FDA announced on November 11, 2020, that RaySearch Laboratories AB voluntarily recalled RayStation and RayPlan software versions due to potential incorrect information in treatment plan reports. The agency issued recall number Z-0589-2021 for the Class II device.
How to tell if you have it
- Brand: RaySearch
- Product: RayStation (versions 4, 4.5, 4.7, 4.9, 5, 6, 7, 8A, 8B, 9A, 9B, 10A)
- Product: RayPlan (versions 1, 2, 7, 8A, 8B, 9A, 9B, 10A)
- Model Numbers: 4.0, 4.5, 4.7, 4.9, 5.0, 6.0, 6.1, 6.2, 6.3, 7.0, 8.0, 8.1, 9.0, 9.1, 9.2, 10.0
- Software Versions: 4.0.0.14, 4.0.3.4, 4.5.1.14, 4.7.2.5, 4.7.3.13, 4.7.4.4, 4.7.5.4, 4.7.6.7, 4.9.0.42, 5.0.1.11, 5.0.2.35, 5.0.3.17, 6.0.0.24, 6.1.1.2, 6.2.0.7, 6.3.0.6, 7.0.0.19, 8.0.0.61, 8.0.1.10, 8.1.0.47, 8.1.1.8, 8.1.2.5, 9.0.0.113, 9.1.0.933, 9.2.0.483, 10.0.0.1154
- Units Affected: 124
The hazard
According to the FDA, two issues were found with the treatment plan report. First, there may be incorrect information for the percent of a region of interest with a clinical goal that is outside the dose grid. Second, for RayStation and RayPlan 9B and 10A, 6D couch angles may be incorrect.
Context
GovInfoNow's records show RaySearch Laboratories AB has 36 other recalls on record since July 17, 2017. Other recent recalls of similar products include Elekta Leksell GammaPlan 11.1 Software Recall (December 12, 2025), Elekta Leksell GammaPlan software version 11.3/11.4 recall (December 12, 2025), and Elekta MOSAIQ Oncology System Software Recall (May 21, 2026).